Lorenz Truemper

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Norbert Schmitz, Maike Nickelsen, Marita Ziepert et al. · The Lancet Oncology · 2012 · 247 citations

Hematological Malignancy, Lymphoid Neoplasia, Conventional Chemotherapy +8

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · The Lancet · 2019 · 244 citations · Full text

Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration

Bjoern Chapuy, Raphael Koch, Ulf K Radunski et al. · Leukemia · 2008 · 154 citations · Full text

Hematological Malignancy, Medicine, Cell Trafficking +9

Gemcitabine as a Single Agent in the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Alexander Fosså, Armando Santoro, Wolfgang Hiddemann et al. · Journal of Clinical Oncology · 1999 · 123 citations

Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone

Raphael Koch, Thiha Aung, Daniel Vogel et al. · Clinical Cancer Research · 2015 · 120 citations